Senna
Product Images NDC 17714-122

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Senna (NDC 17714-122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advance Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Senna 8.6mg (Senna 8.6mg)

Drug Facts label panel for Senna Tablets by Advance Pharmaceutical Inc., listing active ingredient sennosides 8.6 mg per tablet as a laxative. The panel includes uses for occasional constipation, warnings about prolonged use, directions for dosage by age group, and other information like sodium content and advice to consult a doctor if conditions persist or for children under 2 years.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.